Sector Bright Spots and M&A Outlook

Jared Holtz discusses Bayer/Bristol read-throughs, Merck upgrade, and expectations for active M&A in 2026.

Play episode from 22:25

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!